CIFoundry
Back to Catalog
Endocrinology
FDA Cleared

Koios DS (Thyroid & Breast Ultrasound AI)

Save to shortlist
Koios Medical, Inc.2024

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

Koios DS is an FDA-cleared AI computer-aided diagnosis (CADx) platform for ultrasound that analyzes thyroid nodules (and breast lesions) and provides an objective assessment of malignancy risk…

FDA:
510(k) K253884 +2 more
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

Koios DS is an FDA-cleared AI computer-aided diagnosis (CADx) platform for ultrasound that analyzes thyroid nodules (and breast lesions) and provides an objective assessment of malignancy risk aligned to standardized reporting systems such as ACR TI-RADS and ATA guidelines for thyroid. For endocrine care, it helps standardize thyroid-nodule characterization and biopsy decisions, reducing variability between readers. Recent clearances include K242130. Koios Medical is the developer.

endocrinologythyroid noduleultrasoundCADxTI-RADSdecision supportFDA-cleared

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is Koios DS (Thyroid & Breast Ultrasound AI) FDA cleared?
The public FDA database has 3 records that our team matched to Koios DS (Thyroid & Breast Ultrasound AI). The most recent is 510(k) K253884 (Koios DS (3.8)), decided Jul 2026. Check that the cleared use matches how you plan to use it.FDA record K253884

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Endocrinology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K253884 · 510(k) · Jul 2026
    Koios DS (3.8)
  • K242130 · 510(k) · Nov 2024
    Koios DS
  • K212616 · 510(k) · Dec 2021
    Koios DS

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (4)Show

Dated events on this listing's public record, newest first.

  1. Sep 13, 2026

    Added to CIFoundry

  2. Jul 2, 2026

    FDA 510(k) K253884 decision datesource

  3. Nov 15, 2024

    FDA 510(k) K242130 decision datesource

  4. Dec 16, 2021

    FDA 510(k) K212616 decision datesource

https://koiosmedical.com/contact/ (Chicago, IL / New York, NY, USA)

Developer

Koios Medical

Koios Medical, Inc.

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.